These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8989050)

  • 21. Rapid pleurodesis for malignant pleural effusions: a pilot study.
    Reddy C; Ernst A; Lamb C; Feller-Kopman D
    Chest; 2011 Jun; 139(6):1419-1423. PubMed ID: 20930006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Talc pleurodesis in pleuropulmonary diseases treatment.
    Ramić N; Krdžalić G; Mušanović N; Konjić F; Umihanić S; Ramić S; Mustedanagić-Mujanović J; Ljuca F; Zerem E
    Med Glas (Zenica); 2014 Aug; 11(2):264-9. PubMed ID: 25082238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thoracoscopic talc poudrage for malignant effusions: should it be the procedure of choice?
    Yim AP; Izzat MB
    Chest; 1997 Oct; 112(4):1148. PubMed ID: 9377939
    [No Abstract]   [Full Text] [Related]  

  • 24. Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis.
    Zhang W; Zhao YL; Li SJ; Zhao YN; Guo NN; Liu B
    J Cardiothorac Surg; 2021 May; 16(1):125. PubMed ID: 33947423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.
    Debeljak A; Kecelj P; Triller N; Letonja S; Kern I; Debevec L; Rozman A
    J BUON; 2006; 11(4):463-7. PubMed ID: 17309178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged survival after talc poudrage for malignant pleural mesothelioma: case series.
    Aelony Y; Yao JF
    Respirology; 2005 Nov; 10(5):649-55. PubMed ID: 16268920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of malignant pleural effusion by pleurodesis with talc].
    Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
    Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor type influences the effectiveness of pleurodesis in malignant effusions.
    Bielsa S; Hernández P; Rodriguez-Panadero F; Taberner T; Salud A; Porcel JM
    Lung; 2011 Apr; 189(2):151-5. PubMed ID: 21331598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
    Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM
    Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Talc pleurodesis for treating malignant pleural effusions.
    Rodriguez-Panadero F
    Chest; 1995 Oct; 108(4):1178-9. PubMed ID: 7555141
    [No Abstract]   [Full Text] [Related]  

  • 31. Homemade talc spray atomizer dedicated to flexible-rigid pleuroscope.
    Boonsarngsuk V; Juthakarn S; Boonsarngsuk W
    Clin Respir J; 2012 Jan; 6(1):40-5. PubMed ID: 21554563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tunneled Pleural Catheter Placement with and without Talc Poudrage for Treatment of Pleural Effusions Due to Congestive Heart Failure.
    Majid A; Kheir F; Fashjian M; Chatterji S; Fernandez-Bussy S; Ochoa S; Cheng G; Folch E
    Ann Am Thorac Soc; 2016 Feb; 13(2):212-6. PubMed ID: 26598967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.
    Dresler CM; Olak J; Herndon JE; Richards WG; Scalzetti E; Fleishman SB; Kernstine KH; Demmy T; Jablons DM; Kohman L; Daniel TM; Haasler GB; Sugarbaker DJ; ; ; ;
    Chest; 2005 Mar; 127(3):909-15. PubMed ID: 15764775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of pleural fluid pH in malignant epithelial mesothelioma after talc poudrage.
    Aelony Y; Yao JF; King RR
    Respiration; 2006; 73(3):334-9. PubMed ID: 16679752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment.
    Habal P; Omran N; Jankovicova K; Krejsek J; Mandak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):234-41. PubMed ID: 25059234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effective treatment of malignant pleural effusion: Thoracoscopic talcum pleurodesis and pleuro-peritoneal shunt].
    Böhle AS; Kurdow R; Dohrmann P; Henne-Bruns D
    Dtsch Med Wochenschr; 1999 Mar; 124(12):341-5. PubMed ID: 10214366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suitable device for thoracoscopic talc poudrage in malignant pleural effusion.
    Billè A; Borasio P; Gisabella M; Errico L; Gatherer R; Ardissone F
    Gen Thorac Cardiovasc Surg; 2011 Jul; 59(7):522-4. PubMed ID: 21751119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Talc pleurodesis in malignant pleural effusions].
    Kolschmann S; Ballin A; Juergens UR; Rohde G; Gessner C; Hammerschmidt S; Wirtz H; Gillissen A
    Pneumologie; 2006 Feb; 60(2):89-95. PubMed ID: 16463249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing approaches to the management of malignant pleural effusions.
    Porcel JM; Lui MM; Lerner AD; Davies HE; Feller-Kopman D; Lee YC
    Expert Rev Respir Med; 2017 Apr; 11(4):273-284. PubMed ID: 28271728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thoracoscopic management of malignant pleural effusions.
    Colt HG
    Clin Chest Med; 1995 Sep; 16(3):505-18. PubMed ID: 8521705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.